TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas - A single-institution experience

Journal of Surgical Oncology

Volumn 104, Issue 1, 2011, Pages 17-21

  Sellner, Franz ^a   Thalhammer, Sabine ^a   Stättner, Stefan ^a   Karner, Josef ^a   Klimpfinger, Martin ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Grading; Neuroendocrine pancreatic carcinoma; Non functioning; Outcome; Staging; TNM categories

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; INSTITUTIONAL CARE; MALE; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ISLET CELL; CARCINOMA, NEUROENDOCRINE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79958128607     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21889     Document Type: Article

References (37)

1. Capella C, Heitz P, Hofler H, et al.: Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995;425:547-560.
2. Solcia E, Kloppel G, Sobin L: WHO histological classification of tumours. Histological typing of endocrine tumours. 2nd edition. Berlin, Heidelberg, New York, Geneva: Springer Verlag; 2000.
3. De Lellis R, Lloyd R, Heitz Ph, et al.: WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004.
4. Rindi G, Klöppel G, Alhmann H, et al.: TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2006;449:395-401. (Pubitemid 44451313)
5. Fischer L, Kleeft J, Esposito L, et al.: Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95:627-635.
6. Ekeblad S, Skogseid B, Dunder K, et al.: Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798-7803.
7. Pape U, Jann H, Mülller-Nordhorn J, et al.: Prognostic relevance of a novel TNM classification system for upper gastroenteropatic neuroendocrine tumors. Cancer 2008;113:256-265.
8. La Rosa S, Klersy C, Uccella S, et al.: Improved histologic and clinicopathological criteria for prognostic evaluation of pancreatic endocrine tumors. Human Pathol 2009;40:30-40.
9. Scarpa A, Mantovani W, Capelli P, et al.: Pancreatic endocrine tumors: Improbe TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 2010;23:824-833.
10. Bilimoria K, Bentrem D, Merkow R, et al.: Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. Am Coll Surg 2007;205:558-563. (Pubitemid 47446316)
11. Klimstra D, Perren A, Öberg K, et al.: Non-functioning tumours and microadenomas. In: De Lellis R, Lloyd R, Heitz Ph, Eng C, editors. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004. pp. 201-204.
12. Dralle H, Krohn S, Karges W, et al.: Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 2004;28:1248-1260. (Pubitemid 40941288)
13. Matthews B, Heniford B, Reardon P, et al.: Surgical experience with non-functioning neuroendocrine tumors of the pancreas. Am Surg 2000;66:1116-1122.
14. Gullo L, Migliori M, Falconi M, et al.: Nonfunctioning endocrine tumors: A multicenter clinical study. Am J Gastroenterol 2003;98:2435-2439. (Pubitemid 37448753)
15. Schindl M, Kaczirek K, Kaserer K, et al.: Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 2000;24:1312-1318.
16. Madura J, Cummings O, Wiebke E, et al.: Nonfunctioning islet cell tumors of the pancreas: A difficult diagnosis but one worth the effort. Am Surg 1997;63:573-577.
17. Kouvaraki M, Solorzano C, Shapiro S, et al.: Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 2005;89:170-185. (Pubitemid 40315914)
18. Hellmann P, Anderson M, Rastad J, et al.: Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 2000;24:1353-1360.
19. Liang H, Wang P, Wang X, et al.: Management of nonfunctioning islet cell tumors. World J Gastroenterol 2004;10:1806-1809. (Pubitemid 38931210)
20. Solorzano C, Lee J, Pisters P, et al.: Nonfunctioning islet cell carcinoma of the pancreas: Survival results in a contemporary series of 163 patients. Surgery 2001;130:1078-1085. (Pubitemid 34014578)
21. Schwab M, Knoll M, Jentschura D, et al.: Hormone-inactive neuroendocrine tumors of the pancreas. Chirurg 1997;68:705-709. (Pubitemid 127531626)
22. You D, Lee H, Palk K, et al.: The outcomes after surgical resection in pancreatic endocrine tumors: An institutional experience. Eur J Surg Oncol 2009;35:728-733.
23. Bonney G, Gomex D, Rahman S, et al.: Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience. J Pancreas (Online) 2008;9: 19-25.
24. Sellner F, Sobhian B, De Santis M, et al.: Well or poorly differentiated non-functioning neuroendocrine carcinoma of the pancreas: A single institution experience with 17 cases. Eur J Surg Oncol 2008;34:191-195.
25. Bettini R, Boninsegna L, Mantovani W, et al.: Prognostic factors at diagnosis and value of WHO classification in a monoinstitutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008;19:903-908. (Pubitemid 351627305)
26. Ferrone C, Tang L, Tomlinson J, et al.: Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? J Clin Oncol 2007;25:5609-5615.
27. La Rosa S, Sessa F, Capella C, et al.: Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996; 429:323-333. (Pubitemid 26421392)
28. Bartsch D, Schilling Th, Ramaswamy A, et al.: Management of nonfunctioning islet cell carcinomas. World J Surg 2000;24: 1418-1424.
29. Madeira I, Terris B, Voss M, et al.: Prognostic factors in patients with endocrine tumors of the duodenopancreatic area. Gut 1998;43:422-427. (Pubitemid 28414926)
30. Durante C, Boukheris H, Dromain C, et al.: Prognostic factors influencing survival from metastatic (stage IV) gastroenteropatic well differentiated endocrine carcinoma. Endocr Relat Cancer 2009;16:585-597.
31. Zerbi A, Falconi M, Rindi G, et al.: Clinicopathological features of pancreatic endocrine tumors: A prospective multi center study in Italy of 297 sporadic cases. Am J Gastroenterol 2010; 105:1421-1429.
32. Franko J, Feng W, Yip L, et al.: Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2158 patients. J Gastrointest Surg 2010;14:541-548.
33. Eriguchi N, Aoyagi S, Hara M, et al.: Nonfunctioning islet cell carcinoma of the pancreas: An evaluation of seven patients who underwent resection followed by long-term survival. Surg Today 1999;29:233-237. (Pubitemid 29119839)
34. Jarufe N, Coldham C, Orug T, et al.: Neuroendocrine tumours of the pancreas: Predictors of survival after surgical management. Dig Surg 2005;22:157-162. (Pubitemid 41330835)
35. Norton J: Surgery for primary pancreatic neuroendocrine tumors. J Gastrointest Surg 2006;10:327-331.
36. Bordi C, Öberg K, Papotti M, et al.: Poorly differentiated endocrine carcinoma. In: De Lellis R, Lloyd R, Heitz Ph, Eng C, editors. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004. pp. 207-208.
37. Alsamarai S, Libutti S, Saif M: Updates in pancreatic neuroendocrine carcinoma. Highlights from the 2010 ASCO Annual Meeting. J Pancreas (Online) 2010;11:336-340.